Longhorn Vaccines and Diagnostics Presents Compelling Data on LHNVD-303 Vaccine for Sepsis Related to Bacterial Infections at the World Vaccine Congress

Written By Van Agens
Van Agens
Previous

Longhorn Vaccines and Diagnostics Validates Efficacy of PrimeStore® Molecular Transport Medium (MTM) to Inactivate Deadly Pathogens
Next

Longhorn Vaccines and Diagnostics Honors World TB Day 2025, Underscoring a Commitment to Eradicating Tuberculosis with PrimeStore® MTM